Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Internet Search
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
General Discussions
Parenting News
Low doses of antianxiety drugs rebalance the autistic brain
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="runawaybunny" data-source="post: 622577" data-attributes="member: 1"><p>New research in mice suggests that autism is characterized by reduced activity of inhibitory neurons and increased activity of excitatory neurons in the brain, but balance can be restored with low doses of a well-known class of drugs currently used in much higher doses to treat anxiety and epileptic seizures. The findings point to a new therapeutic approach to managing autism.</p><p></p><p>"These are very exciting results because they suggest that existing drugs—called benzodiazepines—might be useful in treatment of the core deficits in autism," says senior author Dr. William Catterall of the University of Washington, in Seattle.</p><p></p><p>In addition to finding that mice with autistic characteristics had an imbalance between the inhibitory and excitatory neurons in their brains, Dr. Catterall and his team found that reducing the effectiveness of inhibitory neurons in normal mice also induced some autism-related deficits in social behavior. Classical benzodiazepine drugs had the opposite effect, increasing the activity of inhibitory neurons and diminishing autistic behaviors.</p><p></p><p>"Our results provide strong evidence that increasing inhibitory neurotransmission is an effective approach to improvement of social interactions, repetitive behaviors, and cognitive deficits in a well-established animal model of autism, having some similar behavioral features as human autism," says Dr. Catterall.</p><p></p><p>Therapeutic approaches to treat autistic traits in animal studies or in clinical trials have primarily focused on reducing the activity of excitatory neurons, with only modest success to date. The results reported by Dr. Catterall and his colleagues suggest that augmenting the activity of opposing, inhibitory neurons could be an alternative strategy.</p><p></p><p>Clinical trials of classical benzodiazepines and next-generation drugs that have a similar mechanism of action are now needed to determine whether the researchers' findings in mice are relevant to humans. Astra-Zeneca and the National Institutes of Health have initiated one such <a href="http://clinicaltrials.gov/show/NCT01966679" target="_blank">trial</a>.</p><p></p><p></p><p>Story Source:</p><p><a href="http://www.cellpress.com" target="_blank">Cell Press</a></p><p></p><p>Study Reference:</p><p>Reported in the Cell Press journal <em>Neuron</em>,</p><p></p><p>Disclaimer:</p><p>This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ConductDisorders or its staff.</p></blockquote><p></p>
[QUOTE="runawaybunny, post: 622577, member: 1"] New research in mice suggests that autism is characterized by reduced activity of inhibitory neurons and increased activity of excitatory neurons in the brain, but balance can be restored with low doses of a well-known class of drugs currently used in much higher doses to treat anxiety and epileptic seizures. The findings point to a new therapeutic approach to managing autism. "These are very exciting results because they suggest that existing drugs—called benzodiazepines—might be useful in treatment of the core deficits in autism," says senior author Dr. William Catterall of the University of Washington, in Seattle. In addition to finding that mice with autistic characteristics had an imbalance between the inhibitory and excitatory neurons in their brains, Dr. Catterall and his team found that reducing the effectiveness of inhibitory neurons in normal mice also induced some autism-related deficits in social behavior. Classical benzodiazepine drugs had the opposite effect, increasing the activity of inhibitory neurons and diminishing autistic behaviors. "Our results provide strong evidence that increasing inhibitory neurotransmission is an effective approach to improvement of social interactions, repetitive behaviors, and cognitive deficits in a well-established animal model of autism, having some similar behavioral features as human autism," says Dr. Catterall. Therapeutic approaches to treat autistic traits in animal studies or in clinical trials have primarily focused on reducing the activity of excitatory neurons, with only modest success to date. The results reported by Dr. Catterall and his colleagues suggest that augmenting the activity of opposing, inhibitory neurons could be an alternative strategy. Clinical trials of classical benzodiazepines and next-generation drugs that have a similar mechanism of action are now needed to determine whether the researchers' findings in mice are relevant to humans. Astra-Zeneca and the National Institutes of Health have initiated one such [URL='http://clinicaltrials.gov/show/NCT01966679']trial[/URL]. Story Source: [URL='http://www.cellpress.com']Cell Press[/URL] Study Reference: Reported in the Cell Press journal [I]Neuron[/I], Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ConductDisorders or its staff. [/QUOTE]
Insert quotes…
Verification
Post reply
Forums
General Discussions
Parenting News
Low doses of antianxiety drugs rebalance the autistic brain
Top